NY-SCEPTER-PARTNERS
Scepter Partners, a leading direct investment and merchant banking platform for sovereign wealth and large cap family offices, announced the appointment of one of its founders, financier Rayo Withanage as Group Chief Executive Officer. In this role, Mr. Withanage will be responsible for leading the expansion and profitability of the Group. HH Prince Abdul Ali Yil Kabier shall continue as chairman of the Board of Stakeholders. Regarding Mr. Withanage’s appointment, HH Prince Abdul Ali, a scion of the Brunei Royal Family, commented, “We are honored to continue under the inspiration and leadership of Mr. Withanage. As he moves to a more executive role, he will drive the financial and strategic dimension of our business, which has the full support of over $14 billion in assets represented by Scepter’s core investors."
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151009005800/en/
Mr. Withanage was named by Euromoney as one of the most influential financiers in the Middle East and Asia, responsible for founding the BMB Group as "the industry's most exclusive commercial multi-family office." Trained as an M&A lawyer, he went into direct investments and began his career as a successful investor in emerging markets before becoming the head of the private investment offices of the co-founders of BMB. Under his leadership and majority ownership, BMB became the first commercial multi-family office of ruling families to unify investors from the Middle East & Asia. Mr. Withanage has an LLB in Law & a BA in Government from The University of Auckland and an MSc from the London School of Economics.
In 2015, the core investors of BMB decided to spin out their assets and combine resources with a number of sovereign and institutional investors to form Scepter. The move was the result of a desire by core investors to develop an institution with significantly more capital, syndication and merchant banking capabilities than a traditional family office. Scepter is now run by Anthony Steains and the former Blackstone Asia Advisory Partners Team. BMB was also refocused to be a specialist advisor and co-investor for Forbes 500 families. BMB, with offices in Bermuda and London, is now led by independent management under its CEO, Rahula Withanage.
About Scepter
Scepter is a standing syndicate of ruling families, ultra-high-net-worth industrialists and sovereign wealth funds. Headquartered in Bermuda with offices in New York and representative offices in London and Beijing, Scepter was founded to acquire large cap assets with a focus in natural resources, infrastructure, real estate and media and telecommunications. As a principal investor, Scepter is supported by the discretionary assets of its core stakeholders and a syndicate of investors who have combined resources to invest in off-market large cap transactions globally. For more information, please visit www.scepterpartners.com .
Legal Notice
Scepter Partners is a principal investor that does not require authorization by the Financial Conduct Authority or the Securities and Exchange Commission or by any financial services regulatory body. Scepter does not have any products open for third party investors. Nothing in this announcement is intended to be, or should be construed as an invitation, offer or inducement to any person or entity to engage in any investment activity.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151009005800/en/
Contact:
Hill+Knowlton Strategies
Joe Millsap, 1-212-885-0464
Joe.Millsap@hkstrategies.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
Illumynt Reports Q3 2025 Business Update17.10.2025 14:39:00 CEST | Press release
Q3 2025 was a busy quarter once again for us here at illumynt. In addition to naming a new CEO, we executed on a number of initiatives that are propelling our organization forward. Revenue for the quarter exceeded $30 million- keeping us on track for our 2025 plan. More importantly we executed three different large-scale data center decommission projects with almost no material ending up as scrap. All of the AI-focused enterprise equipment and components recovered from the decommissions were resold at top market value. We head into Q4 with high expectations and our eyes wide open. We’re celebrating the 20-year anniversary of our facility in Hong Kong and looking to add another location in the region to help us process inbound AI data center equipment. Stay tuned for updates. There will be more on the way. View source version on businesswire.com: https://www.businesswire.com/news/home/20251017446548/en/
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom